PMS and PMDD: Identification and treatment

Patient Care

Volumn 35, Issue 2, 2001, Pages 29-50

  Young, Melinda ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042694545     PISSN: 0031305X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Endicott J, Amsterdam J, Eriksson E, et al. Roundtable Discussion. Is Premenstrual Dysphoric Disorder a Distinct Clinical Entity? J Womens Health Gend Based Med. 1999;8:663-679.
2. Ling FW, Mortola JF, Pariser SF, et al. Premenstrual Syndrome and Premenstrual Dysphoric Disorder: Scope, Diagnosis, and Treatment. APGO Educational Series on Women's Health Issues; published by the Association of Professors of Gynecology and Obstetricians, Washington, DC. 1998:1-28.
3. Eriksson E. Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria. Int Clin Psychopharmacol. 1999;14:S27-S33.
4. Steiner M, Korzekwa M, Lamont J, et al. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria. Psychopharmacol Bull. 1997;33:771-774.
5. Su TP, Schmidt PJ, Danaceau MA, et al. Fluoxetine in the treatment of premenstrual dysphoria. Neuropsychopharmacology. 1997;16:346-356.
6. Romano S, Judge R, Dillon J, et al. The role of fluoxetine in the treatment of premenstrual dysphoric disorder. Clin Ther. 1999;21:615-633.
7. Yonkers KA, Gullion C, Williams A, et al. Paroxetine as a treatment for premenstrual dysphoric disorder. J Clin Psychopharmacol. 1996;16:3-8.
8. Freeman EW, Sondheimer SJ, Polansky M, et al. Predictors of response to sertraline treatment of severe premenstrual syndromes. J Clin Psychiatry. 2000;61:579-584.
9. Pearlstein TB, Halbreich U, Batzar ED, et al. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. J Clin Psychiatry. 2000;61:101-109.
10. Evans SM, Haney M, Levin FR, et al. Mood and performance changes in women with premenstrual dysphoric disorder: acute effects of alprazolam. Neuropsychopharmacology. 1998;19:499-516.
11. Brown CS, Ling FW, Farmer RG, et al. Buspirone in the treatment of premenstrual syndrome. Drug Ther Suppl. 1990:112-121.
12. Rickels K, Freeman E, Sondheimer S. Buspirone in treatment of premenstrual syndrome [letter]. Lancet. 1989;1:777.
13. Barnard ND, Scialli AR, Hurlock D, et al. Diet and Sex-Hormone Binding Globulin, Dysmenorrhea, and Premenstrual Symptoms. Obstet Gynecol 2000;95:245-250.
14. Campbell EM, Peterkin D, O'Grady K, et al. Premenstrual symptoms in general practice patients. Prevalence and treatment. J Reprod Med. 1997;42: 637-646.
15. Singh BB, Berman BM, Simpson RL, et al. Incidence of premenstrual syndrome and remedy usage: a national probability sample study. Altern Ther Health Med. 1998;4:75-79.